Low Velocity Impact Damage in Filament-Wound Composite Pressure Bottles by Highsmith, AL, Ledbetter, FE, Nettles, A, Russell, SS

Get full text

An improved process for preparing tris(N-methylamino)methylsilane monomer for use in producing silicon carbide-silicon nitride fibers by Penn, Benjamin G, Ledbetter, Frank E, Clemons, Johnny M

Get full text

Predicting compression set in elastomeric materials by Bower, Mark V., Ledbetter, Frank E.

Get full text

The Cognitive and Behavioral Phenotype of the 16p11.2 Deletion in a Clinically Ascertained Population by Hanson, Ellen, Bernier, Raphael, Porche, Ken, Jackson, Frank I, Goin-Kochel, Robin P, Snyder, LeeAnne Green, Snow, Anne V, Wallace, Arianne Stevens, Campe, Katherine L, Zhang, Yuan, Chen, Qixuan, D’Angelo, Debra, Moreno-De-Luca, Andres, Orr, Patrick T, Boomer, K.B, Evans, David W, Kanne, Stephen, Berry, Leandra, Miller, Fiona K, Olson, Jennifer, Sherr, Elliot, Martin, Christa L, Ledbetter, David H, Spiro, John E, Chung, Wendy K

Get full text

QS39. Outcomes of Curative Intent Treatment For Prostate Cancer Among Patients With Total Visual Impairment by Van Eps, Jeffrey L, Virgo, Katherine S, Johnson, Frank E, Feman, Stephen S, Ledbetter, Luke N, Kumar, Mohit

Get full text

Molecular confirmation of Wolf-Hirschhorn syndrome with a subtle translocation of chromosome 4 by ALTHERR, M. R, BENGTSSON, U, ELDER, F. F. B, LEDBETTER, D. H, WASMUTH, J. J, MCDONALD, M. E, GUSELLA, J. F, GREENBERG, F

Get full text

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo‐controlled phase I/II trial of CAT‐192 by Denton, Christopher P., Merkel, Peter A., Furst, Daniel E., Khanna, Dinesh, Emery, Paul, Hsu, Vivien M., Silliman, Nancy, Streisand, James, Powell, John, Åkesson, Anita, Coppock, John, Hoogen, Frank van den, Herrick, Ariane, Mayes, Maureen D., Veale, Douglas, Haas, Joanna, Ledbetter, Stephen, Korn, Joseph H., Black, Carol M., Seibold, James R.

Get full text

Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 by Denton, Christopher P, Merkel, Peter A, Furst, Daniel E, Khanna, Dinesh, Emery, Paul, Hsu, Vivien M, Silliman, Nancy, Streisand, James, Powell, John, Aakesson, Anita, Coppock, John, Van den Hoogen, Frank, Herrick, Ariane, Mayes, Maureen D, Veale, Douglas, Haas, Joanna, Ledbetter, Stephen, Korn, Joseph H, Black, Carol M, Seibold, James R

Get full text

Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 by Denton, Christopher P, Merkel, Peter A, Furst, Daniel E, Khanna, Dinesh, Emery, Paul, Hsu, Vivien M, Silliman, Nancy, Streisand, James, Powell, John, Akesson, Anita, Coppock, John, Hoogen, Frank van den, Herrick, Ariane, Mayes, Maureen D, Veale, Douglas, Haas, Joanna, Ledbetter, Stephen, Korn, Joseph H, Black, Carol M, Seibold, James R

Get full text